| Literature DB >> 28514687 |
Paola Martinez-Murillo1, Karen Tran2, Javier Guenaga2, Gustaf Lindgren3, Monika Àdori1, Yu Feng2, Ganesh E Phad1, Néstor Vázquez Bernat1, Shridhar Bale2, Jidnyasa Ingale2, Viktoriya Dubrovskaya2, Sijy O'Dell4, Lotta Pramanik1, Mats Spångberg5, Martin Corcoran1, Karin Loré3, John R Mascola4, Richard T Wyatt6, Gunilla B Karlsson Hedestam7.
Abstract
The development of soluble envelope glycoprotein (Env) mimetics displaying ordered trimeric symmetry has ushered in a new era in HIV-1 vaccination. The recently reported native, flexibly linked (NFL) design allows the generation of native-like trimers from clinical isolates at high yields and homogeneity. As the majority of infections world-wide are of the clade C subtype, we examined responses in non-human primates to well-ordered subtype C 16055 trimers administered in soluble or high-density liposomal formats. We detected superior germinal center formation and enhanced autologous neutralizing antibodies against the neutralization-resistant (tier 2) 16055 virus following inoculation of liposome-arrayed trimers. Epitope mapping of the neutralizing monoclonal antibodies (mAbs) indicated major contacts with the V2 apex, and 3D electron microscopy reconstructions of Fab-trimer complexes revealed a horizontal binding angle to the Env spike. These vaccine-elicited mAbs target the V2 cap, demonstrating a means to accomplish tier 2 virus neutralization by penetrating the dense N-glycan shield.Entities:
Keywords: B cell responses; HIV-1; clade C; envelope glycoproteins; epitope; germinal centers; liposome; monoclonal antibody; trimers; vaccine
Mesh:
Substances:
Year: 2017 PMID: 28514687 PMCID: PMC5528178 DOI: 10.1016/j.immuni.2017.04.021
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745